Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.27%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
120.28 Down 2.67(2.17%) Apr 24, 4:00PM EDT
|After Hours : 119.00 Down 1.28 (1.06%) Apr 24, 7:42PM EDT
Add to Portfolio
Prev Close:122.95
Open:122.38
Bid:117.50 x 100
Ask:124.80 x 300
1y Target Est:127.21
Beta:1.04
Next Earnings Date:30-Apr-15BMRN Earnings announcement
Day's Range:120.21 - 123.14
52wk Range:55.36 - 133.54
Volume:821,847
Avg Vol (3m):1,516,960
Market Cap:19.14B
P/E (ttm):N/A
EPS (ttm):-0.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BMRNDown 2.17%19.14B
FOLDDown 0.41%1.18B
SHPGDown 0.10%49.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.31
Quarterly EPS Est (Mar-15) :-0.53
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-2.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback